InsidersTradesSigma
Track the HeartSciences Inc. share price and the full insider trade history of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €9.2m. The latest transaction was reported on 24 June 2026 (Attribution). Among the most active insiders: Simpson Andrew. The full history is free.
Analysts rate HeartSciences Inc. Strong Buy (bullish), based on 2 analysts. Average price target: US$10.00.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
HeartSciences Inc. is a company focused on developing diagnostic solutions for heart diseases. It aims to leverage advanced technologies to enhance early detection of cardiac issues.